JOHN MIDDLETON: Open Payments
NPI 1427160720 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,417 in 28 payments from 6 companies in 2025. Trend: 2023 $1,701 · 2024 $5,135 · 2025 $3,417
Debt forgiveness: $2,750Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 1 | $2,750 |
| Alkermes, Inc. | 11 | $294 |
| Otsuka America Pharmaceutical, Inc. | 8 | $178 |
| Axsome Therapeutics, Inc. | 3 | $93 |
| E.R. Squibb & Sons, L.L.C. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, ARISTADA, Auvelity, REXULTI, COBENFY, ABILIFY ASIMTUFII, ABILIFY MAINTENA, CAPLYTA.
Industry payments across CA — which companies pay providers there.
